Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,652 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update in systemic therapy of urologic malignancies.
Mooney D, Paluri R, Mehta A, Goyal J, Sonpavde G. Mooney D, et al. Among authors: mehta a. Postgrad Med. 2014 Jan;126(1):44-54. doi: 10.3810/pgm.2014.01.2724. Postgrad Med. 2014. PMID: 24393751 Review.
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evens AM, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. Epperla N, et al. Among authors: mehta a. Cancer. 2017 Nov 15;123(22):4411-4418. doi: 10.1002/cncr.30895. Epub 2017 Jul 27. Cancer. 2017. PMID: 28749548 Free article.
A review of chimeric antigen receptor T-cells in lymphoma.
Anderson JK, Mehta A. Anderson JK, et al. Among authors: mehta a. Expert Rev Hematol. 2019 Jul;12(7):551-561. doi: 10.1080/17474086.2019.1629901. Epub 2019 Jun 19. Expert Rev Hematol. 2019. PMID: 31177852 Review.
Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.
Agarwal N, Bellmunt J, Maughan BL, Boucher KM, Choueiri TK, Qu AQ, Vogelzang NJ, Fougeray R, Niegisch G, Albers P, Wong YN, Ko YJ, Sridhar SS, Tantravahi SK, Galsky MD, Petrylak DP, Vaishampayan UN, Mehta AN, Beer TM, Sternberg CN, Rosenberg JE, Sonpavde G. Agarwal N, et al. Clin Genitourin Cancer. 2014 Apr;12(2):130-7. doi: 10.1016/j.clgc.2013.09.002. Epub 2013 Sep 28. Clin Genitourin Cancer. 2014. PMID: 24220220 Free PMC article.
Tivozanib: status of development.
Jamil MO, Hathaway A, Mehta A. Jamil MO, et al. Among authors: mehta a. Curr Oncol Rep. 2015 Jun;17(6):24. doi: 10.1007/s11912-015-0451-3. Curr Oncol Rep. 2015. PMID: 25895472 Review.
Treatment approaches of hard-to-treat non-Hodgkin lymphomas.
Nandagopal L, Mehta A. Nandagopal L, et al. Among authors: mehta a. Expert Rev Hematol. 2017 Mar;10(3):259-273. doi: 10.1080/17474086.2017.1283214. Epub 2017 Feb 15. Expert Rev Hematol. 2017. PMID: 28094575 Review.
5,652 results